| Nomenclature | Peroxisome proliferator‐activated receptor‐α | Peroxisome proliferator‐activated receptor‐β/δ | Peroxisome proliferator‐activated receptor‐γ |
| Systematic nomenclature | NR1C1 | NR1C2 | NR1C3 |
| HGNC, UniProt | PPARA, Q07869 | PPARD, Q03181 | PPARG, P37231 |
| Selective agonists | GW7647 [17, 18], CP‐775146 [67], pirinixic acid [155], gemfibrozil [31] | GW0742X [50, 148], GW501516 [112] | GW1929 [17], bardoxolone (Partial agonist) [149], rosiglitazone [59, 80, 86, 161], troglitazone [59, 161], pioglitazone [7, 59, 127, 161], ciglitazone [59] |
| Selective antagonists | GW6471 (pIC50 6.6) [158] | GSK0660 (pIC50 6.5) [131] | T0070907 (pK i 9) [77], GW9662 (Irreversible inhibition) (pIC50 8.1) [78], CDDO‐Me (pK i 6.9) [149] |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.